Newsroom

For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.

To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.

Feature: Synapse of Discovery Jan 5, 2015

The Djavad Mowafaghian Centre for Brain Health is highlighted in this Winter 2015 feature on UBC.ca.

+
Changing the pace of memory loss Dec 9, 2014

Researchers at the Djavad Mowafaghian Centre for Brain Health, in collaboration with scientists at the Chongqing Medical University in Chongqing, China, recently discovered a way to slow the deterioration of memory. These findings significantly advance our understanding of the mechanism by which memory in our brain decays, and are the first to establish an opportunity for intervention to slow the progression of Alzheimer’s disease (AD) and related dementias.

+
Turning some Ideas on their Head: Dr. Adele Diamond, TEDxWestVancouverED Nov 26, 2014

Dr. Adele Diamond speaks to the power of executive function and its impact on student learning in this TEDxWestVancouverEd talk. 

+
NMO Clinic and Research Program joins multi-centre study Nov 20, 2014

Collaborative International Research in Clinical and Longitudinal Experience for NMO Studies

In North America, Neuromyelitis Optica (NMO) affects four in 100,000 people, and can cause loss of vision in one or both eyes (optic neuritis) and numbness and weakness in the arms and legs (transverse myelitis). It is an unpredictable and chronic illness that is often confused with Multiple Sclerosis, but NMO is a distinct disease requiring different treatment. 

+
Teen girls playing soccer
Teenage brains may be more vulnerable to lasting injury Nov 19, 2014

Young athletes who experience concussions may need to wait longer than currently recommended before getting ‘back in the game’ because of the unique brain developmental stage of adolescence, according to new research. The study, published in the Journal of Neurotrauma, shows that current adult-based standards for assessing the effects of concussions and length of time to recovery may be inadequate for adolescents.

+
Predicting adverse drug reactions in patients with Multiple Sclerosis Nov 17, 2014

Interferon beta (IFN-β) is a disease-modifying drug used to reduce the risk of a future relapse (attacks) in people with multiple sclerosis (MS) by modulating the immune system. And while IFN-β is considered safe, it does hold a small possibility of side effects, including liver injury. While 30 to 60 per cent of individuals with MS treated with IFN-β will experience elevations in their liver enzyme test results, these elevations are often transient and disappear even with continued IFN-β treatment. 

+
Neuromyelitis Optica (NMO) Information Day Oct 23, 2014

The third annual Neuromyelitis Optica (NMO) Information Day will be held at the Djavad Mowafaghian Centre for Brain Health (DMCBH) on November 1, from 10:00 a.m. to 4:00 p.m.

+
Researcher profile: Dr. Haakon Nygaard Oct 21, 2014

Dr. Haakon Nygaard comes to the Djavad Mowafaghian Centre for Brain Health (DMCBH) from Yale University, where he completed his internship in Internal Medicine, Residency in Neurology, and a PhD in Investigative Medicine under the mentorship of Dr. Stephen Strittmatter. He joined the Yale faculty as an Assistant Professor in Neurology, and during this time he co-founded the first Alzheimer’s clinic at Yale, and was the founding director of the Yale Behavioral Neurology and Neuropsychiatry fellowship program. Dr.

+
Taking a risk or playing it safe is influenced by dopamine signals Oct 20, 2014

For the better part of a century, the neurotransmitter dopamine has been understood as a key player in the brain’s reward-related processing. Djavad Mowafaghian Centre for Brain Health and Vancouver Coastal Health Research Institute researcher Dr. Stan Floresco has discovered more precisely that bursts and dips of dopamine activity in the brain guide the level of risk taken when making a choice.

+
Researcher profile: Dr. Dan Marigold Oct 16, 2014

In order to pursue discovery and improve the mobility of people with eye disease and other neurological conditions, Dr. Marigold’s research combines basic science with clinically relevant scenarios.

+

Pages